Parathyroid Carcinoma Is Difficult to Distinguish Histologically from Benign Parathyroid Disease

2015 ◽  
Vol 27 (3) ◽  
pp. 68-71
Author(s):  
Matthew Miller ◽  
Wendy Sacks
2021 ◽  
pp. 014556132110362
Author(s):  
Shinpei Kada ◽  
Miho Tanaka ◽  
Akihiro Yasoda

Parathyroid carcinoma is a rare endocrine tumor. Parathyroid carcinoma in patients with secondary hyperparathyroidism due to chronic kidney disease is also rare. In addition, thyroid hemiagenesis is a rare congenital anomaly. We report an extremely rare case of parathyroid carcinoma in a patient with secondary hyperparathyroidism and thyroid hemiagenesis. We also present a review of the literature of this rare entity. We also discuss the surgical procedure performed for this patient. Our review of the literature found 34 case reports of parathyroid carcinoma in patients undergoing dialysis due to chronic renal failure; 14 reports of thyroid hemiagenesis with parathyroid disease; and no previous reports of thyroid hemiagenesis with secondary hyperparathyroidism and parathyroid carcinoma. Although surgical treatment of parathyroid carcinoma requires combined resection with the thyroid, peritracheal dissection with total parathyroidectomy, and monitoring intact parathyroid hormone as a tumor marker, our procedure preserved the patient’s thyroid function. There has been no evidence of recurrence for over 8 years.


2015 ◽  
Vol 21 ◽  
pp. 143
Author(s):  
Elizabeth Sanchez Rangel ◽  
Maria Moscoso Cordero ◽  
Vinuta Mohan ◽  
Tasneem Zahra

2017 ◽  
Vol 23 ◽  
pp. 135
Author(s):  
Ahmad Elayyan ◽  
Sindhura Bandaru ◽  
Alexandria McDow ◽  
Joseph White ◽  
Carmel Fratianni ◽  
...  

2017 ◽  
Vol 23 ◽  
pp. 111
Author(s):  
Corin Badiu ◽  
Lidia Radomi ◽  
Daniel Mihai ◽  
Dumitru Ioachim

2014 ◽  
Vol 122 (03) ◽  
Author(s):  
R Jumpertz-von Schwartzenberg ◽  
U Elbelt ◽  
M Ventz ◽  
C Strasburger ◽  
J Spranger

2010 ◽  
Vol 49 (06) ◽  
pp. N62-N62 ◽  
Author(s):  
C. Maier-Funk ◽  
T. Weber ◽  
G. Lang ◽  
S. Hügl ◽  
S. N. Reske ◽  
...  

1997 ◽  
Vol 36 (07) ◽  
pp. 256-258 ◽  
Author(s):  
G. F. Fueger ◽  
S. Lax ◽  
Reingard Aigner

SummaryRecent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.


Author(s):  
Joo Yul Choi ◽  
Young Bum Kim ◽  
Guk Haeng Lee ◽  
Myung-Chul Lee

Sign in / Sign up

Export Citation Format

Share Document